Dr. Stephen DePasquale, MD
Claim this profileChattanooga's Program in Women's Oncology
Area of expertise
Ovarian Cancer
Stephen DePasquale, MD has run 4 trials for Ovarian Cancer. Some of their research focus areas include:
Peritoneal Cancer
Stephen DePasquale, MD has run 4 trials for Peritoneal Cancer. Some of their research focus areas include:
Affiliated Hospitals
Chattanooga's Program In Women's Oncology
University Of Tennessee At Chattanooga
Clinical Trials Stephen DePasquale, MD is currently running
Olvi-Vec + Chemotherapy
for Ovarian Cancer
The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and primary peritoneal cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objective response rate and progression-free survival observed in heavily pre-treated patients with platinum-resistant/refractory ovarian cancer. The phase II results also showed that the intra-peritoneal route of delivery was efficient in generating tumor cell killing and immune activation, and led to clinical reversal of platinum-resistance or refractoriness in this difficult-to-treat patient population.
Recruiting
2 awards
Phase 3
7 criteria
Robotic vs Open Hysterectomy
for Cervical Cancer
This is a randomized controlled trial to compare survival for patients who undergoe robotic assisted laparoscopy versus open hysterectomy and lymph node assessment for the treatment of early stage cervical cancer.
Recruiting
1 award
N/A
8 criteria
More about Stephen DePasquale, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Stephen DePasquale, MD has experience with
- Carboplatin
- GEN-1
- VMD-928
- Bevacizumab
- Olvimulogene Nanivacirepvec
- Gemcitabine
Breakdown of trials Stephen DePasquale, MD has run
Ovarian Cancer
Peritoneal Cancer
Fallopian Tube Cancer
Cervical Cancer
Throat Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephen DePasquale, MD specialize in?
Stephen DePasquale, MD focuses on Ovarian Cancer and Peritoneal Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Stephen DePasquale, MD currently recruiting for clinical trials?
Yes, Stephen DePasquale, MD is currently recruiting for 4 clinical trials in Chattanooga Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Stephen DePasquale, MD has studied deeply?
Yes, Stephen DePasquale, MD has studied treatments such as Carboplatin, GEN-1, VMD-928.
What is the best way to schedule an appointment with Stephen DePasquale, MD?
Apply for one of the trials that Stephen DePasquale, MD is conducting.
What is the office address of Stephen DePasquale, MD?
The office of Stephen DePasquale, MD is located at: Chattanooga's Program in Women's Oncology, Chattanooga, Tennessee 37403 United States. This is the address for their practice at the Chattanooga's Program in Women's Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.